Trust, transparency, affordability: engaging patients for fair IRA drug pricing

31 Jan 2024

Written by Jason Spangler (Innovation and Value Initiative), Kistein Monkhouse (Patient Orator)

Guest columns Health economics Market access Patient engagement Stakeholder engagement Value assessment

Image of Kistein Monkhouse and Jason Spangler on a green background with the title of their column discussing patient engagement in the Inflation Reduction Act

The Inflation Reduction Act (IRA) proposes a significant initiative, the Drug Price Negotiation Program (DPNP), aimed at tackling healthcare affordability and accessibility in the US. In this guest column, Kistein Monkhouse, MPA, from Patient Orator and Jason Spangler MD, MPH, FACPM, from the Innovation and Value Initiative underscore the importance of meaningful patient engagement during the IRA's implementation as a vital step towards improving health outcomes and equity for patients. Designing the drug price negotiation program for and with patients The IRA represents a potentially significant step towards making health care more affordable and accessible for all Americans. A key...